Bank of New York Mellon Corp Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Bank of New York Mellon Corp boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 27.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 2,403,110 shares of the medical instruments supplier's stock after purchasing an additional 523,692 shares during the quarter. Bank of New York Mellon Corp owned about 1.21% of DENTSPLY SIRONA worth $45,611,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Nordea Investment Management AB raised its stake in shares of DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock worth $4,754,000 after purchasing an additional 178,639 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after buying an additional 1,244,326 shares in the last quarter. Barclays PLC raised its position in DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after buying an additional 54,920 shares during the last quarter. Canvas Wealth Advisors LLC lifted its stake in DENTSPLY SIRONA by 126.5% during the 4th quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier's stock valued at $6,245,000 after acquiring an additional 182,234 shares during the period. Finally, Quantinno Capital Management LP boosted its holdings in shares of DENTSPLY SIRONA by 276.5% during the 3rd quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier's stock valued at $3,161,000 after acquiring an additional 85,787 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Remove Ads

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY traded down $0.27 during midday trading on Monday, reaching $16.05. The stock had a trading volume of 2,782,706 shares, compared to its average volume of 2,597,309. The company has a market capitalization of $3.19 billion, a price-to-earnings ratio of -7.75, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12-month low of $15.47 and a 12-month high of $34.28. The stock has a 50-day moving average of $18.54 and a 200-day moving average of $21.14. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 3.99%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.52% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on XRAY. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. UBS Group lowered their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a report on Tuesday, December 3rd. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating for the company in a report on Friday, February 28th. Morgan Stanley lowered their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a report on Tuesday, December 17th. Finally, Robert W. Baird cut their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $23.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.